Sold as Suprax. Every FDA application for this active ingredient: 4 branded and 13 generic.
As of Nov 13, 2026, FDA lists 17 applications for Cefixime (sold as Suprax), first approved Apr 28, 1989, with 6 new uses approved and 0 published complete response letters.
| Product | Part | Spending, 2024 | Change | Beneficiaries |
|---|---|---|---|---|
| Cefixime | Part D | $1.9M | -13% | 14,341 |
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Apr 28, 1989 | SupraxNDA 50621 · New molecular entity | Lederle | 26 | Discontinued |
| Apr 28, 1989 | SupraxNDA 50622 · New dosage form | Lederle | 20 | Discontinued |
| Feb 12, 2004 | SupraxANDA 65130 | Lupin Pharms | 3 | Discontinued |
| Feb 23, 2004 | SupraxANDA 65129 | Lupin Pharms | 6 | Discontinued |
| Apr 10, 2007 | SupraxANDA 65355 | Lupin Pharms | 2 | Marketed |
| Oct 25, 2010 | SupraxANDA 65380 | Lupin Ltd | 2 | Discontinued |
| Jun 1, 2012 | SupraxNDA 203195 · New dosage form | Lupin Ltd | 8 | Marketed |
| Feb 20, 2013 | SupraxNDA 202091 · New formulation or manufacturer | Lupin Ltd | 8 | Marketed |
| Apr 14, 2015 | CefiximeANDA 204835 | Aurobindo Pharma Ltd | 1 | Marketed |
| Feb 6, 2017 | CefiximeANDA 206938 | Ajenat Pharms | 0 | Marketed |
| Feb 6, 2017 | CefiximeANDA 206939 | Ajenat Pharms | 0 | Marketed |
| Nov 17, 2017 | CefiximeANDA 206144 | Chartwell Rx | 0 | Discontinued |
| Oct 9, 2018 | CefiximeANDA 210574 | Alkem Labs Ltd | 0 | Marketed |
| Feb 19, 2021 | CefiximeANDA 211775 | Alkem Labs Ltd | 0 | Marketed |
| Dec 17, 2024 | CefiximeANDA 206358 | Fdc Ltd | 0 | Marketed |
| Mar 23, 2026 | CefiximeANDA 217607 | Aurobindo Pharma Ltd | 0 | Marketed |
| May 14, 2026 | CefiximeANDA 218691 | Fdc Ltd | 0 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number. Drugs@FDA
